Singapore markets open in 8 hours 22 minutes

Cytosorbents Corporation (CTSO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.9300-0.0100 (-1.06%)
As of 12:32PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-27,539
-28,507
-32,813
-24,559
-7,837
-
Depreciation & amortisation
2,156
2,027
1,132
1,130
660.788
-
Stock-based compensation
3,545
3,701
3,800
6,204
4,708
-
Change in working capital
-2,358
2,361
-3,562
641.899
-757.869
-
Accounts receivable
-
-
-1,288
420.578
-326.86
-642.171
Inventory
-1,994
-121.039
945.352
-2,351
-461.512
-
Other working capital
-23,757
-22,591
-34,690
-18,287
-7,290
-
Other non-cash items
42.857
42.857
-
-
322.812
115.206
Net cash provided by operating activities
-23,377
-21,655
-28,234
-14,006
-5,613
-
Cash flows from investing activities
Investments in property, plant and equipment
-380.37
-936.236
-6,456
-4,281
-1,676
-
Net cash used for investing activities
-380.37
-936.236
-6,456
-4,281
-1,676
-
Cash flows from financing activities
Debt repayment
-
-
0
0
-16,411
0
Common stock issued
13,667
14,256
-
-
80,214
673.653
Common stock repurchased
-
-
-40.358
-90
-
-
Other financing activities
-
-
-
-
-375
-4.212
Net cash used provided by (used for) financing activities
13,218
14,474
4,960
715.199
66,348
-
Net change in cash
-10,644
-8,217
-29,993
-17,596
59,189
-
Cash at beginning of period
20,736
23,832
53,825
71,422
12,232
-
Cash at end of period
10,197
15,615
23,832
53,825
71,422
-
Free cash flow
Operating cash flow
-23,377
-21,655
-28,234
-14,006
-5,613
-
Capital expenditure
-380.37
-936.236
-6,456
-4,281
-1,676
-
Free cash flow
-23,757
-22,591
-34,690
-18,287
-7,290
-